⌘K

Login Start Free

Home/Insiders/Harmon Seth

HS

SEC Insider//CIK 0001993300

Harmon Seth

CIK 00019933001 companyWALTHAM, MA

Transactions

9

Companies

1

Filings

4

CIK

0001993300

Recent Transactions

9 trades

Tax Payment
Viridian Therapeutics, Inc.\DE$VRDN
Common Stock
2026-03-03$30.19/sh−2,031→ 7,850 total
Exercise/Conversion
Viridian Therapeutics, Inc.\DE$VRDN
Common Stock
2026-03-03+6,267→ 9,881 total
Tax Payment
Viridian Therapeutics, Inc.\DE$VRDN
Common Stock
2026-03-03$29.32/sh−2,091→ 7,790 total
Exercise/Conversion
Viridian Therapeutics, Inc.\DE$VRDN
Restricted Stock Units
2026-03-03−6,267→ 18,801 total
Award
Viridian Therapeutics, Inc.\DE$VRDN
Stock Option (Right to Buy)
2026-03-02+102,850→ 102,850 total
Award
Viridian Therapeutics, Inc.\DE$VRDN
Restricted Stock Units
2026-03-02+20,550→ 20,550 total
Award
Viridian Therapeutics, Inc.\DE$VRDN
Restricted Stock Units
2025-03-03+25,068→ 25,068 total
Award
Viridian Therapeutics, Inc.\DE$VRDN
Stock Option (Right to Buy)
2025-03-03+150,407→ 150,407 total
Award
Viridian Therapeutics, Inc.\DE$VRDN
Stock Option (Right to Buy)
2023-11-10+270,000→ 270,000 total

Companies

1

Viridian Therapeutics, Inc.\DE
Chief Financial Officer
$VRDN

Recent Filings

4

Address

C/O VIRIDIAN THERAPEUTICS, INC. 221 CRESCENT STREET, SUITE 103A

WALTHAM, MA, 02453

View on SEC.gov